MedTrace Logo

Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer

NCT00078390 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2018-05-02

No results posted yet for this study

Summary

A study to measure the safety and effectiveness of S-3304 when given in combination with conventional chemo-radiation therapy in patients with locally advanced non-small cell lung cancer.

Conditions

  • Non Small Cell Lung Cancer
  • Lung Cancer
  • Stage IIIA Non Small Cell Lung Cancer
  • Stage IIIB Non Small Cell Lung Cancer

Interventions

DRUG

S-3304

S-3304 will be administered at the tolerable dose BID along with chemo-irradiation

OTHER

Chemo-irradiation

Standard of care chemo-irradiation

Sponsors & Collaborators

  • Shionogi

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28
Primary Completion
2006-09-28
Completion
2006-10-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00078390 on ClinicalTrials.gov